Yu-Tang Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yu-Tang Gao has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Xiao-Ou Shu
Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37203, USA
14 shared publications Wei Zheng
Vandverbilt University Medical Centre, Nashville, USA
11 shared publications- Qiuyin Cai
Affiliation Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America
10 shared publications Fan Jin
Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China
6 shared publications- Bu-Tian Ji
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
5 shared publications - Qi Dai
Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
5 shared publications
Latest Publications
- 1 September 2016
- Published by BMJ
- Vol. 73, A90-A91
O47-6 Impact of calibrating a benzene job-exposure matrix with measurements on exposure-response associations for non-hodgkin lymphoma
Objectives To provide insight into the contributions of exposure measurements to job exposure matrices (JEMs), we examined the sensitivity of exposure-response associations between occupational benzene exposure and non-Hodgkin lymphoma (NHL) using benzene JEM-based estimates with and without measurement calibration. Methods NHL risk was examined in a prospective population-based cohort of 73,087 Shanghai women with no prevalent cancer at baseline and a valid occupational history. An ‘uncalibrated’ benzene JEM was developed using expert judgment to assign ordinal (0 to 3) probability and intensity ratings to each occupation and industry group. JEM intensity estimates were combined with >60,000 short-term, area benzene inspection measurements using a mixed-effects model framework that incorporated fixed effects for year and intensity rating and random effects for occupation, industry, and measurement occurrence. The model was used to derive ‘calibrated JEM’ estimates from the fixed effect model parameters and ‘job/industry-specific’ estimates from both the fixed effect model parameters and the best unbiased linear prediction estimates from the occupation and industry random effect terms. Cumulative exposure for each subject was calculated for each approach using varying exposure definition criteria based on the JEM’s probability ratings. We examined the agreement between the cumulative metrics and evaluated changes in the benzene-NHL associations. Results For our primary exposure definition, the job/industry-specific estimates were moderately to highly correlated with the calibrated and uncalibrated JEM estimates (Spearman correlation amongst exposed subjects: 0.64–0.87). The uncalibrated, calibrated, and job/industry-specific metrics all resulted in statistically significant exposure-response associations for NHL, with similar model fit. This similarity occurred because the measurement- and ordinal-based weights across the occupation intensity ratings were nearly identical in this study. Conclusions The measurement-based JEM estimates had similar model fit to the uncalibrated JEM estimates in this study; however, the measurement-based estimates allowed us to evaluate quantitative exposure-response curves.
- 1 September 2016
- Published by BMJ
- Vol. 73, A90-A91
O47-6 Impact of calibrating a benzene job-exposure matrix with measurements on exposure-response associations for non-hodgkin lymphoma
Objectives To provide insight into the contributions of exposure measurements to job exposure matrices (JEMs), we examined the sensitivity of exposure-response associations between occupational benzene exposure and non-Hodgkin lymphoma (NHL) using benzene JEM-based estimates with and without measurement calibration. Methods NHL risk was examined in a prospective population-based cohort of 73,087 Shanghai women with no prevalent cancer at baseline and a valid occupational history. An ‘uncalibrated’ benzene JEM was developed using expert judgment to assign ordinal (0 to 3) probability and intensity ratings to each occupation and industry group. JEM intensity estimates were combined with >60,000 short-term, area benzene inspection measurements using a mixed-effects model framework that incorporated fixed effects for year and intensity rating and random effects for occupation, industry, and measurement occurrence. The model was used to derive ‘calibrated JEM’ estimates from the fixed effect model parameters and ‘job/industry-specific’ estimates from both the fixed effect model parameters and the best unbiased linear prediction estimates from the occupation and industry random effect terms. Cumulative exposure for each subject was calculated for each approach using varying exposure definition criteria based on the JEM’s probability ratings. We examined the agreement between the cumulative metrics and evaluated changes in the benzene-NHL associations. Results For our primary exposure definition, the job/industry-specific estimates were moderately to highly correlated with the calibrated and uncalibrated JEM estimates (Spearman correlation amongst exposed subjects: 0.64–0.87). The uncalibrated, calibrated, and job/industry-specific metrics all resulted in statistically significant exposure-response associations for NHL, with similar model fit. This similarity occurred because the measurement- and ordinal-based weights across the occupation intensity ratings were nearly identical in this study. Conclusions The measurement-based JEM estimates had similar model fit to the uncalibrated JEM estimates in this study; however, the measurement-based estimates allowed us to evaluate quantitative exposure-response curves.
- Open Access
- 23 June 2014
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 71 (Suppl 1) , A42.2-A42
0346 Occupational Exposure to Lead and Cancer in Two Cohort Studies of Men and Women in Shanghai, China
Objectives Epidemiologic studies of occupational lead exposure have suggested increased risks of cancers of the brain, kidney, lung, meninges, and stomach; however, the totality of the evidence is inconsistent. To clarify whether lead is a carcinogen, we investigated the relationship between occupational lead exposure and risks of these five cancer sites in two prospective cohort studies in Shanghai, China. Method Annual job/industry-specific estimates of lead fume and lead dust exposure were derived from a statistical model that combined expert ratings of lead intensity with inspection measurements collected by the Shanghai Centre for Disease Control and Prevention. The job/industry estimates were applied to the lifetime work histories of subjects from the Shanghai Women’s Health Study (73 363 participants) and the Shanghai Men’s Health Study (61 379 participants) to estimate cumulative exposure to lead dust and lead fume. Cohort-specific relative hazard rate ratios (RRs) and 95% confidence intervals (CI) were estimated using Cox proportional hazards regression models and then pooled using a random effects meta-analysis model. Results We observed a statistically significant increased risk of meningioma among individuals with estimated occupational exposure to lead dust or fumes (RR=2.4, 95% CI:1.1–5.0), and in particular among those with an above-median cumulative exposure to dust or fumes (RR=3.1, 95% CI:1.3–7.4). We observed suggestive associations with lead exposure for cancers of the kidney (RR=1.4, 95% CI:0.9–2.3) and brain (RR=1.8, 95% CI:0.7–4.8), and null findings for cancers of the lung and stomach. Conclusions Our findings provide additional evidence that occupational lead exposure increases risk of meningioma.
- 23 June 2014
- Published by BMJ in Occupational and Environmental Medicine
- Vol. 71 (Suppl 1) , A42.2-A42
Open Access0346 Occupational Exposure to Lead and Cancer in Two Cohort Studies of Men and Women in Shanghai, China
Objectives Epidemiologic studies of occupational lead exposure have suggested increased risks of cancers of the brain, kidney, lung, meninges, and stomach; however, the totality of the evidence is inconsistent. To clarify whether lead is a carcinogen, we investigated the relationship between occupational lead exposure and risks of these five cancer sites in two prospective cohort studies in Shanghai, China. Method Annual job/industry-specific estimates of lead fume and lead dust exposure were derived from a statistical model that combined expert ratings of lead intensity with inspection measurements collected by the Shanghai Centre for Disease Control and Prevention. The job/industry estimates were applied to the lifetime work histories of subjects from the Shanghai Women’s Health Study (73 363 participants) and the Shanghai Men’s Health Study (61 379 participants) to estimate cumulative exposure to lead dust and lead fume. Cohort-specific relative hazard rate ratios (RRs) and 95% confidence intervals (CI) were estimated using Cox proportional hazards regression models and then pooled using a random effects meta-analysis model. Results We observed a statistically significant increased risk of meningioma among individuals with estimated occupational exposure to lead dust or fumes (RR=2.4, 95% CI:1.1–5.0), and in particular among those with an above-median cumulative exposure to dust or fumes (RR=3.1, 95% CI:1.3–7.4). We observed suggestive associations with lead exposure for cancers of the kidney (RR=1.4, 95% CI:0.9–2.3) and brain (RR=1.8, 95% CI:0.7–4.8), and null findings for cancers of the lung and stomach. Conclusions Our findings provide additional evidence that occupational lead exposure increases risk of meningioma.
- 1 September 2012
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 23
P-225
- Open Access
- 1 May 2007
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (5) , 917-920
Expression of Cytochrome P450 1B1 and Catechol-O-Methyltransferase in Breast Tissue and Their Associations with Breast Cancer Risk
Cytochrome P450 1B1 (CYP1B1) and catechol-O-methyltransferase (COMT) are important estrogen-metabolizing enzymes that may affect breast cancer risk. Few studies have directly measured the expression of CYP1B1 and COMT genes in breast tissue samples. The subjects in this study were a subgroup of participants of the Shanghai Breast Cancer Study including 64 patients diagnosed with breast cancer and 68 patients diagnosed with benign breast diseases (BBD) who provided samples of tumor tissue and adjacent nontumor tissue to the study. We compared CYP1B1 and COMT mRNA expression in tumor tissue and adjacent nontumor tissue in both breast cancer patients and BBD patients. High levels of CYP1B1 expression and low levels of COMT expression in adjacent nontumor tissue were associated with a significantly increased breast cancer risk in a nonlinear manner. Odds ratios and 95% confidence intervals (in parentheses) for the midpoints of the first, second, fourth, and fifth quintiles of gene expression levels compared with the overall median levels in BBD subjects were 0.21 (0.07-0.67), 0.81 (0.69-0.95), 1.20 (1.05-1.38), and 1.55 (1.12-2.15) for CYP1B1 and 1.72 (1.17-2.55), 1.19 (1.05-1.35), 0.83 (0.73-0.95), and 0.78 (0.65-0.93) for COMT, respectively. These results support the hypothesis that the formation and accumulation of catechol estrogens in breast tissue through increased CYP1B1 expression and reduced COMT expression may play a significant role in breast cancer risk. (Cancer Epidemiol Biomarkers Prev 2007;16(5):917–20)
- 1 May 2007
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (5) , 917-920
Open AccessExpression of Cytochrome P450 1B1 and Catechol-O-Methyltransferase in Breast Tissue and Their Associations with Breast Cancer Risk
Cytochrome P450 1B1 (CYP1B1) and catechol-O-methyltransferase (COMT) are important estrogen-metabolizing enzymes that may affect breast cancer risk. Few studies have directly measured the expression of CYP1B1 and COMT genes in breast tissue samples. The subjects in this study were a subgroup of participants of the Shanghai Breast Cancer Study including 64 patients diagnosed with breast cancer and 68 patients diagnosed with benign breast diseases (BBD) who provided samples of tumor tissue and adjacent nontumor tissue to the study. We compared CYP1B1 and COMT mRNA expression in tumor tissue and adjacent nontumor tissue in both breast cancer patients and BBD patients. High levels of CYP1B1 expression and low levels of COMT expression in adjacent nontumor tissue were associated with a significantly increased breast cancer risk in a nonlinear manner. Odds ratios and 95% confidence intervals (in parentheses) for the midpoints of the first, second, fourth, and fifth quintiles of gene expression levels compared with the overall median levels in BBD subjects were 0.21 (0.07-0.67), 0.81 (0.69-0.95), 1.20 (1.05-1.38), and 1.55 (1.12-2.15) for CYP1B1 and 1.72 (1.17-2.55), 1.19 (1.05-1.35), 0.83 (0.73-0.95), and 0.78 (0.65-0.93) for COMT, respectively. These results support the hypothesis that the formation and accumulation of catechol estrogens in breast tissue through increased CYP1B1 expression and reduced COMT expression may play a significant role in breast cancer risk. (Cancer Epidemiol Biomarkers Prev 2007;16(5):917–20)
- Open Access
Expression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival
BACKGROUND. The ataxia‐telangiectasia mutated (ATM) gene plays a critical role in cell‐cycle arrest, apoptosis, and DNA repair. However, to date, no study has directly investigated the association between ATM gene expression and breast cancer survival. METHODS. ATM gene expression levels were evaluated in tumor and adjacent normal tissue from patients diagnosed with primary breast cancer or BBD using quantitative real‐time reverse transcription polymerase chain reaction (RT‐PCR) assays. Cox regression models were used to evaluate the association of ATM gene expression and survival in a cohort of 471 breast cancer patients. RESULTS. In breast cancer cases, ATM expression in cancer tissues was decreased by approximately 50% compared with adjacent normal tissues from the same patients. In BBD cases, the expression level of the ATM gene was similar in benign tumor tissue and adjacent normal tissues. No apparent difference was found in ATM gene expression levels in adjacent normal tissues obtained from cancer patients or BBD controls. Compared with patients with the lowest tertile of the ATM mRNA, patients in the upper 2 tertiles had more favorable disease‐free survival (hazard ratio [HR] = 0.46, 95% confidence interval [CI]: 0.30–0.73 and HR = 0.52, 95% CI: 0.33–0.81, respectively) and overall survival (HR = 0.56, 95% CI: 0.35–0.92 and HR = 0.70, 95% CI: 0.43–1.13, respectively). CONCLUSIONS. The ATM gene expression was down‐regulated in breast cancer tissues and a high ATM gene expression level in breast cancer tissue was associated with a favorable prognosis. Cancer 2007. © 2007 American Cancer Society.
Open AccessExpression patterns of the ATM gene in mammary tissues and their associations with breast cancer survival
BACKGROUND. The ataxia‐telangiectasia mutated (ATM) gene plays a critical role in cell‐cycle arrest, apoptosis, and DNA repair. However, to date, no study has directly investigated the association between ATM gene expression and breast cancer survival. METHODS. ATM gene expression levels were evaluated in tumor and adjacent normal tissue from patients diagnosed with primary breast cancer or BBD using quantitative real‐time reverse transcription polymerase chain reaction (RT‐PCR) assays. Cox regression models were used to evaluate the association of ATM gene expression and survival in a cohort of 471 breast cancer patients. RESULTS. In breast cancer cases, ATM expression in cancer tissues was decreased by approximately 50% compared with adjacent normal tissues from the same patients. In BBD cases, the expression level of the ATM gene was similar in benign tumor tissue and adjacent normal tissues. No apparent difference was found in ATM gene expression levels in adjacent normal tissues obtained from cancer patients or BBD controls. Compared with patients with the lowest tertile of the ATM mRNA, patients in the upper 2 tertiles had more favorable disease‐free survival (hazard ratio [HR] = 0.46, 95% confidence interval [CI]: 0.30–0.73 and HR = 0.52, 95% CI: 0.33–0.81, respectively) and overall survival (HR = 0.56, 95% CI: 0.35–0.92 and HR = 0.70, 95% CI: 0.43–1.13, respectively). CONCLUSIONS. The ATM gene expression was down‐regulated in breast cancer tissues and a high ATM gene expression level in breast cancer tissue was associated with a favorable prognosis. Cancer 2007. © 2007 American Cancer Society.
- 20 February 2007
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 50 (4) , 265-273
Occupation and adult‐onset asthma among chinese women in a population‐based cohort
Background Exposure to industrial irritants is believed to have contributed to the increasing prevalence of asthma worldwide. We examined the associations between occupation and asthma among women in a case‐control study nested in the population‐based Shanghai Women's Health Study cohort in China. Methods Cases were 1,050 women who reported a physician‐diagnosed asthma as adults. Controls were 4,200 women matched to the cases by year of birth and age at diagnosis. Lifetime occupational histories were obtained. Logistic regression was applied to estimate odds ratios (ORs) adjusting for smoking, education, family income, and concurrent chronic bronchitis. Results Asthma is more prevalent in production industries for metal tools (OR = 2.4; 1.3–4.7), metal products for everyday use (OR = 1.6; 1.1–2.4), ships (OR = 2.6; 1.0–6.8), and clocks (OR = 1.9; 1.0–3.4), and in occupations as farm workers (OR = 4.0; 1.2–13.0), laboratory technicians and analyzers (OR = 2.2; 1.2‐3.9), and installation and maintenance workers for weaving and knitting machineries (OR = 2.4; 1.1–5.4). Other associations less commonly reported were identified for electricians (OR = 2.1; 1.1–4.1), performers (OR = 3.2; 1.4–7.4), administrative workers in organizations and enterprises (OR = 1.8; 1.1–2.8), and postal and telecommunication workers (OR = 3.5; 1.6–7.6). Conclusions Our findings suggest that occupational exposures contribute to the development of asthma in women. Am. J. Ind. Med. 2007.
- 20 February 2007
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 50 (4) , 265-273
Occupation and adult‐onset asthma among chinese women in a population‐based cohort
Background Exposure to industrial irritants is believed to have contributed to the increasing prevalence of asthma worldwide. We examined the associations between occupation and asthma among women in a case‐control study nested in the population‐based Shanghai Women's Health Study cohort in China. Methods Cases were 1,050 women who reported a physician‐diagnosed asthma as adults. Controls were 4,200 women matched to the cases by year of birth and age at diagnosis. Lifetime occupational histories were obtained. Logistic regression was applied to estimate odds ratios (ORs) adjusting for smoking, education, family income, and concurrent chronic bronchitis. Results Asthma is more prevalent in production industries for metal tools (OR = 2.4; 1.3–4.7), metal products for everyday use (OR = 1.6; 1.1–2.4), ships (OR = 2.6; 1.0–6.8), and clocks (OR = 1.9; 1.0–3.4), and in occupations as farm workers (OR = 4.0; 1.2–13.0), laboratory technicians and analyzers (OR = 2.2; 1.2‐3.9), and installation and maintenance workers for weaving and knitting machineries (OR = 2.4; 1.1–5.4). Other associations less commonly reported were identified for electricians (OR = 2.1; 1.1–4.1), performers (OR = 3.2; 1.4–7.4), administrative workers in organizations and enterprises (OR = 1.8; 1.1–2.8), and postal and telecommunication workers (OR = 3.5; 1.6–7.6). Conclusions Our findings suggest that occupational exposures contribute to the development of asthma in women. Am. J. Ind. Med. 2007.
- Open Access
- 8 January 2007
- Published by Springer Nature in Breast Cancer Research
- Vol. 9 (1) , R2
IGFBP3mRNA expression in benign and malignant breast tumors
Introduction: Most previous studies have focused on evaluating the association between circulating insulin-like growth factor binding protein 3 (IGFBP-3) levels and breast cancer risk. Emerging evidence over the past few years suggests that IGFBP-3 may act directly on mammary epithelial cells. Methods: To understand the role of IGFBP-3 in breast tumorigenesis, we investigated IGFBP3 mRNA expression levels in benign and malignant breast tumors and their adjacent normal tissues using real-time quantitative PCR. Results: Cancer tissues had significantly lower IGFBP3 expression than benign tumor tissues (p < 0.001). IGFBP3 expressions in both tumor and adjacent tissues were higher in patients who had proliferative benign tumors than in those who had non-proliferative benign tumors. Among patients with benign breast disease, IGFBP3 expression in the tumor was significantly higher than that in their adjacent normal tissue. There were no apparent associations of IGFBP3 expression in cancer tissues with either overall survival or disease-free survival in a cohort of 521 patients with breast cancer. Conclusion: Our findings suggest that the expression level of IGFBP3 in breast tissues may be involved in breast tumorigenesis.
- 8 January 2007
- Published by Springer Nature in Breast Cancer Research
- Vol. 9 (1) , R2
Open AccessIGFBP3mRNA expression in benign and malignant breast tumors
Introduction: Most previous studies have focused on evaluating the association between circulating insulin-like growth factor binding protein 3 (IGFBP-3) levels and breast cancer risk. Emerging evidence over the past few years suggests that IGFBP-3 may act directly on mammary epithelial cells. Methods: To understand the role of IGFBP-3 in breast tumorigenesis, we investigated IGFBP3 mRNA expression levels in benign and malignant breast tumors and their adjacent normal tissues using real-time quantitative PCR. Results: Cancer tissues had significantly lower IGFBP3 expression than benign tumor tissues (p < 0.001). IGFBP3 expressions in both tumor and adjacent tissues were higher in patients who had proliferative benign tumors than in those who had non-proliferative benign tumors. Among patients with benign breast disease, IGFBP3 expression in the tumor was significantly higher than that in their adjacent normal tissue. There were no apparent associations of IGFBP3 expression in cancer tissues with either overall survival or disease-free survival in a cohort of 521 patients with breast cancer. Conclusion: Our findings suggest that the expression level of IGFBP3 in breast tissues may be involved in breast tumorigenesis.
- Open Access
- 1 March 2006
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (3) , 586-588
MTRandMTRRPolymorphisms, Dietary Intake, and Breast Cancer Risk
The Shanghai Breast Cancer Study is a large population-based case-control study conducted in urban Shanghai, China. Detailed study methods have been published previously (12). In brief, cases ages between 25 and 64 years were identified through a rapid case-ascertainment system supplemented by the population-based Shanghai Cancer Registry. Controls were identified from the Shanghai Resident Registry and frequency matched to the expected age distribution of cases by 5-year age groups. All subjects completed an in-person interview. Dietary intakes were assessed using a 76-item food frequency questionnaire that captured >85% of food intake in Shanghai (13). Blood samples were collected from 1,193 (82%) cases and 1,310 (84%) controls and used in this study for genotyping assays. MTRR Ile22Met (A66G, rs1801394) genotyping was done using the Taqman 5′-Nuclease Assay (C_3068176_10; Applied Biosystems, Foster City, CA). MTR Asp919Gly (A2756G, rs1805087) genotyping was done by BioServe Biotechnologies Ltd. (Laurel, MD) using Masscode assay (14). The consistency rate of quality control samples was 100% for MTR A2756G and 96% for MTRR A66G.
- 1 March 2006
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 15 (3) , 586-588
Open AccessMTRandMTRRPolymorphisms, Dietary Intake, and Breast Cancer Risk
The Shanghai Breast Cancer Study is a large population-based case-control study conducted in urban Shanghai, China. Detailed study methods have been published previously (12). In brief, cases ages between 25 and 64 years were identified through a rapid case-ascertainment system supplemented by the population-based Shanghai Cancer Registry. Controls were identified from the Shanghai Resident Registry and frequency matched to the expected age distribution of cases by 5-year age groups. All subjects completed an in-person interview. Dietary intakes were assessed using a 76-item food frequency questionnaire that captured >85% of food intake in Shanghai (13). Blood samples were collected from 1,193 (82%) cases and 1,310 (84%) controls and used in this study for genotyping assays. MTRR Ile22Met (A66G, rs1801394) genotyping was done using the Taqman 5′-Nuclease Assay (C_3068176_10; Applied Biosystems, Foster City, CA). MTR Asp919Gly (A2756G, rs1805087) genotyping was done by BioServe Biotechnologies Ltd. (Laurel, MD) using Masscode assay (14). The consistency rate of quality control samples was 100% for MTR A2756G and 96% for MTRR A66G.
- Open Access
- 10 May 2005
- Published by Springer Nature in Breast Cancer Research
- Vol. 7 (4) , R506-12
Genetic polymorphisms in the matrix metalloproteinase 12 gene (MMP12) and breast cancer risk and survival: the Shanghai Breast Cancer Study
Introduction: Matrix metalloproteinase 12 (MMP12) is a proteolytic enzyme responsible for cleavage of plasminogen to angiotensin, which has an angiostatic effect. Using data from a population-based case–control study conducted among Chinese women in Shanghai, we evaluated the association of breast cancer risk and survival with two common polymorphisms in the MMP12 gene: A-82G in the promoter region and A1082G in exon, resulting in an amino acid change of asparagine to serine. Methods: Included in the study were 1,129 cases and 1,229 age-frequency-matched population controls. Breast cancer patients were followed up to determine the intervals of overall survival and disease-free survival. Results: The frequencies of the G allele in the A-82G and A1082G polymorphism among controls were 0.029 and 0.107, respectively. There were no associations between MMP12 polymorphisms and breast cancer risk. Patients with the AG or GG genotype of the A1082G polymorphism showed poorer overall survival (though the difference was not statistically significant) than patients with the AA genotype (hazard ratio 1.36, 95% CI 0.92 to 2.00). Conclusion: This result suggests that MMP12 A1082G polymorphism may be related to prognosis in breast cancer patients. Additional studies with larger sample sizes are warranted.
- 10 May 2005
- Published by Springer Nature in Breast Cancer Research
- Vol. 7 (4) , R506-12
Open AccessGenetic polymorphisms in the matrix metalloproteinase 12 gene (MMP12) and breast cancer risk and survival: the Shanghai Breast Cancer Study
Introduction: Matrix metalloproteinase 12 (MMP12) is a proteolytic enzyme responsible for cleavage of plasminogen to angiotensin, which has an angiostatic effect. Using data from a population-based case–control study conducted among Chinese women in Shanghai, we evaluated the association of breast cancer risk and survival with two common polymorphisms in the MMP12 gene: A-82G in the promoter region and A1082G in exon, resulting in an amino acid change of asparagine to serine. Methods: Included in the study were 1,129 cases and 1,229 age-frequency-matched population controls. Breast cancer patients were followed up to determine the intervals of overall survival and disease-free survival. Results: The frequencies of the G allele in the A-82G and A1082G polymorphism among controls were 0.029 and 0.107, respectively. There were no associations between MMP12 polymorphisms and breast cancer risk. Patients with the AG or GG genotype of the A1082G polymorphism showed poorer overall survival (though the difference was not statistically significant) than patients with the AA genotype (hazard ratio 1.36, 95% CI 0.92 to 2.00). Conclusion: This result suggests that MMP12 A1082G polymorphism may be related to prognosis in breast cancer patients. Additional studies with larger sample sizes are warranted.
- Open Access
- 1 December 2004
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 13 (12) , 2065-2070
Synergistic Effects of STK15 Gene Polymorphisms and Endogenous Estrogen Exposure in the Risk of Breast Cancer
STK15 is a member of a family of serine/threonine kinases that act as key regulators of chromosome segregation and cytokinesis. Over expression of the STK15 gene leads to centrosome amplification, chromosomal instability, aneuploidy, and transformation. It has been reported that the 91T → A (Phe → Ile at codon 31) polymorphism in the STK15 gene affects the function of this gene. We hypothesized that this polymorphism may interact with endogenous estrogen exposure in the risk of breast cancer and evaluated this hypothesis in a population-based, case-control study conducted among Chinese women in Shanghai. Genotyping assays were completed for 1,102 incident cases and 1,186 community controls. Participation and blood donation rates were over 90% and 80%, respectively. Elevated risks of breast cancer were found to be associated with the Phe/Ile [odds ratio (OR), 1.3; 95% confidence interval (CI), 1.0-1.7] and Ile/Ile (OR, 1.2; 95% CI, 0.9-1.6) genotypes at codon 31 of the STK15 gene, although the ORs were not statistically significant. The risk associated with this polymorphism was modified by factors related to endogenous estrogen exposure, such as high body mass index (BMI), high waist-to-hip ratio, long duration of lifetime menstruation, or long duration of menstruation before first live birth. In particular, a statistically significant interaction was found between BMI and the STK15 Phe31Ile polymorphism (P = 0.02) and a positive association with breast cancer risk for the Ile allele was found only among overweight (BMI ≥ 25 kg/m2) women with adjusted ORs (95% CIs) of 3.3 (1.4-7.7) and 4.1 (1.7-9.8) associated with the Phe/Ile and Ile/Ile genotypes (Pfor trend invitro and in vivo experiments, implicating an etiologic role of the STK15 gene in human breast cancer, and provide evidence for the modifying effects of genetic background on human cancer risk.
- 1 December 2004
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 13 (12) , 2065-2070
Open AccessSynergistic Effects of STK15 Gene Polymorphisms and Endogenous Estrogen Exposure in the Risk of Breast Cancer
STK15 is a member of a family of serine/threonine kinases that act as key regulators of chromosome segregation and cytokinesis. Over expression of the STK15 gene leads to centrosome amplification, chromosomal instability, aneuploidy, and transformation. It has been reported that the 91T → A (Phe → Ile at codon 31) polymorphism in the STK15 gene affects the function of this gene. We hypothesized that this polymorphism may interact with endogenous estrogen exposure in the risk of breast cancer and evaluated this hypothesis in a population-based, case-control study conducted among Chinese women in Shanghai. Genotyping assays were completed for 1,102 incident cases and 1,186 community controls. Participation and blood donation rates were over 90% and 80%, respectively. Elevated risks of breast cancer were found to be associated with the Phe/Ile [odds ratio (OR), 1.3; 95% confidence interval (CI), 1.0-1.7] and Ile/Ile (OR, 1.2; 95% CI, 0.9-1.6) genotypes at codon 31 of the STK15 gene, although the ORs were not statistically significant. The risk associated with this polymorphism was modified by factors related to endogenous estrogen exposure, such as high body mass index (BMI), high waist-to-hip ratio, long duration of lifetime menstruation, or long duration of menstruation before first live birth. In particular, a statistically significant interaction was found between BMI and the STK15 Phe31Ile polymorphism (P = 0.02) and a positive association with breast cancer risk for the Ile allele was found only among overweight (BMI ≥ 25 kg/m2) women with adjusted ORs (95% CIs) of 3.3 (1.4-7.7) and 4.1 (1.7-9.8) associated with the Phe/Ile and Ile/Ile genotypes (Pfor trend invitro and in vivo experiments, implicating an etiologic role of the STK15 gene in human breast cancer, and provide evidence for the modifying effects of genetic background on human cancer risk.